Held‐Feindt et al., 2002 - Google Patents
CD70/CD27 ligand, a member of the TNF family, is expressed in human brain tumorsHeld‐Feindt et al., 2002
- Document ID
- 17322999971748672673
- Author
- Held‐Feindt J
- Mentlein R
- Publication year
- Publication venue
- International journal of cancer
External Links
Snippet
Abstract CD70 (CD27 ligand) has been implicated in proapoptotic signals mediated by its receptor CD27 in lymphocytes as well as in proliferative effects induced by reverse signaling in CD70‐positive hematopoetic tumor cells. We were able to show that CD70 is expressed …
- 102100005830 CD70 0 title abstract description 21
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Held‐Feindt et al. | CD70/CD27 ligand, a member of the TNF family, is expressed in human brain tumors | |
KR102606210B1 (en) | Oligomeric particle reagents and methods of use thereof | |
JP7390334B2 (en) | Methods for culturing cells and kits and devices therefor | |
KR102644950B1 (en) | Methods for the treatment of b cell malignancies using adoptive cell therapy | |
Michel et al. | A soluble form of CD137 (ILA/4‐1BB), a member of the TNF receptor family, is released by activated lymphocytes and is detectable in sera of patients with rheumatoid arthritis | |
Dong et al. | B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion | |
Eagle et al. | ULBP6/RAET1L is an additional human NKG2D ligand | |
Borst et al. | CD27 and CD70 in T cell and B cell activation | |
Huard et al. | T cell costimulation by the TNF ligand BAFF | |
Sabbagh et al. | ERK-dependent Bim modulation downstream of the 4-1BB-TRAF1 signaling axis is a critical mediator of CD8 T cell survival in vivo | |
JP2018531035A6 (en) | Method for culturing cells and kit and apparatus therefor | |
AU2012290342A1 (en) | Switch costimulatory receptors | |
CN107365798B (en) | CD19-CAR-T cell carrying iCasp9 suicide gene and application thereof | |
Ungefroren et al. | Immunological escape mechanisms in pancreatic carcinoma | |
Prigione et al. | Immunogenicity of human neuroblastoma | |
JP2022546932A (en) | Chimeric co-stimulatory receptors and methods and uses thereof | |
CN117355327A (en) | CAR NKT expressing SHRNA embedded in artificial microRNAs for down-regulating MHC class I and class II expression | |
Katayama et al. | A possible role for the loss of CD27–CD70 interaction in myelomagenesis | |
Kusumoto et al. | Epithelial membrane protein 3 (Emp3) downregulates induction and function of cytotoxic T lymphocytes by macrophages via TNF-α production | |
Gerl et al. | The intracellular 52‐kd Ro/SSA autoantigen in keratinocytes is up‐regulated by tumor necrosis factor α via tumor necrosis factor receptor I | |
Haux et al. | The role of interleukin-2 in regulating the sensitivity of natural killer cells for Fas-mediated apoptosis | |
Zhong et al. | T cell stimulation and expansion by SunTag-based clustering of anti-CD3/CD28 scFv | |
JP2021524743A (en) | Method of optimizing NK-92 cell proliferation using poloxamer | |
Mizuno et al. | Molecular cloning of feline tumour necrosis factor receptor type I (TNFR I) and expression of TNFR I and TNFR II in lymphoid cells in cats | |
Ji et al. | Roles of semaphorins in the immune and hematopoietic system |